Christopher Peetz - 10 May 2022 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
President and CEO, Director
Signature
/s/ Jody Howe, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
10 May 2022
Net transactions value
+$20,349
Form type
4
Filing time
12 May 2022, 21:17:36 UTC
Previous filing
07 Jan 2022
Next filing
14 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common STock Award $20,349 +1,500 +2.2% $13.57 69,527 10 May 2022 Direct F1
holding MIRM Common Stock 201,570 10 May 2022 By The Peetz Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 1,500 shares by the Reporting Person on May 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.